Mark Gustavson

Company: AstraZeneca

Job title: Senior Director, Oncology Translational Medicine

Seminars:

Computational Pathology – the Next Revolution in Companion Diagnostics 2:30 pm

IHC is commonly used to measure target levels of ADCs despite the fact that it is semi-quantitative Sharing a method developed using image analysis and computational methods to score membrane targets with a continuous quantitative manner This method enables target expression per cell to be measured and allows for the modelling of bystander effectsRead more

day: Day One